RESUMEN
Quantification of beta-lactam antibiotics can be performed by using liquid chromatography in combination with tandem mass spectrometry (MS/MS) or ultraviolet (UV) detection. Since beta-lactam antibiotics are known as highly polar analytes, using standard reversed phase chromatography will result in very early elution, which is often not desirable. Some retention is preferred to reduce matrix effects, because a high amount of non-retained molecular matrix species elute early from the column. For highly polar analytes, ultra-performance convergence chromatography (UPC2) may be a suitable alternative. This method is based on supercritical fluid chromatography. To our knowledge, we developed the first UPC2-MS/MS method for the determination of amoxicillin, benzylpenicillin, flucloxacillin, piperacillin, cefotaxime, cefuroxime, ceftazidime, imipenem, meropenem, and the free fraction of cefuroxime and flucloxacillin in human plasma. The method was validated according to the Food and Drug Administration guidelines. The method was found linear (r2 >0.990) for all analytes. The inaccuracies and imprecisions were < 15% for all analytes. The matrix effect and recovery were nearly all consistent with coefficient of variation of less than 15% and no significant carryover effect was observed. Furthermore, this method was found to be suitable for daily routine analysis in hospital settings, requiring only 50 µL of plasma. This novel, sensitive, and specific UPC2-MS/MS method demonstrated its value in the analysis of a more than 800 human plasma samples in a clinical trial using simple and fast sample preparation and short analysis run time of only 5 min.
